Full-Time

Lead SAP ABAP Developer

Posted on 5/9/2026

Cencora

Cencora

10,001+ employees

Global pharmaceutical distribution and services provider

No salary listed

Pune, Maharashtra, India

In Person

Category
Software Engineering (1)
Requirements
  • Bachelor’s Degree in Computer Science, Information Technology or any other related discipline or equivalent related experience.
  • Current SAP certification is desired.
  • Requires training in fields such as information systems computer sciences or similar vocations obtained through completion of a four-year bachelor’s degree program; requires a minimum of five (10+) years directly related and progressively responsible experience designing building testing and deploying enterprise SAP solutions (certification preferred) . In-depth experience in ABAP Workbench, ABAP Objects, BAPI, BADI’s, IDOCs, BDC and ALV Programming.
  • Experience and strong understating of SAP coding techniques in software engineering such as work processes, parallel processing, interface techniques, enhancement techniques , DDIC and ABAP tuning.
  • Basic experience in SAP Fiori (on-premise and cloud) and web user interface technologies : SAPUI5, and Web IDE.
  • Familiarity with capabilities of SAP HANA is desired but not required for this role.
  • Extending existing S/4, and/or writing entirely new S/4 programs and functions , CDS tools using ABAP in Eclipse (ADT), and ABAP Managed Database Procedures (AMDP).
Responsibilities
  • SAP ECC Technical (ABAP) support and enhancements. The system has a roadmap to migrate to S4 and this role will become an SAP S4 technical role in the future.
  • Analyzes system operations through monitoring, capacity analysis and root cause analysis to identify and drive change that ensures continuous improvement in system stability and performance.
  • Assists in the overall maintenance and support of the efficient software solutions. Collaborates with technology teams across the Organization to leverage resources and expertise, establish software best practices and standards, and build for partnerships with IT teams.
  • Responsible for program designs, development, unit testing, peer reviews in an SAP ABAP environment.
  • Responsible for identifying development tasks in support of project planning and estimation.
  • Participates in and makes performance recommendations to code during peer reviews.
  • Works with functional and business users to troubleshoot issues in production.
  • Strong knowledge and hands on experience of software development life cycle (SDLC), modeling of business processes, application design patterns, and business/functional documents.
  • Supports the building and maintenance of an Enterprise portfolio to support Application capabilities lifecycle and roadmap initiatives.
  • Advises business areas in the analysis of innovative technologies and how they impact the broader Enterprise Architecture
  • Analyzes industry standards and trends in integration technologies.
  • Provides technical leadership, coaching, and mentoring to team members.
  • Conducts SAP unit testing to ensure systems meets user specifications.
  • Requires increased skill in multiple technical environments and knowledge of a specific business area.
  • May participate in the project planning process with team members.
  • May meet with process team to analyze business processes, understand requirements, and recommend technical solutions...
  • May analyzes existing SAP platform to identify weaknesses and develop opportunities for improvements, when assigned.
  • Troubleshoots existing information systems to identify errors or deficiencies and develop solutions.
  • Works with functional users to troubleshoot issues in production.
  • Troubleshoots and resolves production problems.
  • Escalates issues to manager and admin and process teams where necessary.
  • Identifies recurring and potential problems and recommends procedures and controls for prevention.
  • Recommends ideas for improving production support.
  • Documents technical design and test activities/results
  • Follows established change control procedures.
  • Provides input to the development and maintenance of development standards for full life cycle implementations or upgrades.
  • Assists in evaluating new SAP application development tools.
  • Demonstrates knowledge of ABAP development
  • Ability to communicate effectively both orally and in writing
  • Strong mathematical and analytical skills
  • Strong organizational skills; attention to detail
  • Good conceptual and problem-solving skills to evaluate business problems and apply applications knowledge to identify appropriate solutions
  • Good interpersonal skills; effective team player
Desired Qualifications
  • Current SAP certification is desired.
  • Familiarity with capabilities of SAP HANA is desired but not required for this role.
  • Basic experience in SAP Fiori (on-premise and cloud) and web user interface technologies : SAPUI5, and Web IDE is desirable.
  • Extending existing S/4, and/or writing entirely new S/4 programs and functions , CDS tools using ABAP in Eclipse (ADT), and ABAP Managed Database Procedures (AMDP) is desirable.

Cencora provides global pharmaceutical distribution and a range of services, including specialty pharmacy, consulting, supply-chain management, patient support programs, and data analytics for healthcare providers, manufacturers, and veterinary practices. It works by combining physical drug distribution with value-added services such as inventory management, regulatory compliance guidance, patient support, and data-driven insights to optimize supply chains and outcomes. The company differentiates itself with an integrated, end-to-end offering that spans distribution, clinical services, analytics, and advisory support to help clients run more efficient operations and lower costs. Its goal is to improve healthcare outcomes by delivering comprehensive pharmaceutical solutions that enable better care and lower overall expenses.

Company Size

10,001+

Company Stage

IPO

Headquarters

Pennsylvania

Founded

1907

Simplify Jobs

Simplify's Take

What believers are saying

  • OneOncology $5B acquisition completed December 2025 boosts specialty oncology leadership.
  • EyeSouth retina business $1.1B deal expands Retina Consultants, accretive to EPS post-closure.
  • FY2026 EPS guidance raised to $17.65–$17.90 despite revenue headwinds from biosimilars.

What critics are saying

  • Frank R. Cruz investigation triggers shareholder lawsuits after May 6, 2026 Q2 revenue miss.
  • McKesson and Cardinal Health seize specialty drug share via aggressive GLP-1 pricing.
  • Inflation Reduction Act price cuts compress margins beyond $2B Q2 2026 headwind.

What makes Cencora unique

  • Cencora rebranded from AmerisourceBergen in August 2023, trading as COR on NYSE.
  • Cencora operates 1,400 locations across 50+ countries for global pharmaceutical distribution.
  • Cencora uniquely serves human and animal health with specialty pharmacy and MSO platforms.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Cencora who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Parental Leave

Adoption Assistance

Infertility Coverage

Family Planning Benefits

Behavioral Health Solutions

Professional Development Budget

Training Programs

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Mar 23rd, 2026
Cencora buys EyeSouth Partners' retina business for $1.1B to expand Retina Consultants of America

Cencora has signed a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. The affiliated retina physicians will join Cencora's Retina Consultants of America, a leading management services organisation. The pharmaceutical solutions company expects the acquisition to be slightly accretive to its adjusted diluted earnings per share in the first twelve months following closure, net of financing costs. The transaction requires regulatory approvals and customary closing conditions. Cencora's reaffirmed fiscal 2026 financial guidance does not currently include the transaction closing within that fiscal year. BofA Securities served as lead financial advisor to Cencora, whilst Jefferies advised EyeSouth Partners, a portfolio company of Olympus Partners.

The Associated Press
Mar 17th, 2026
Cencora CFO James Cleary to retire after eight years, search underway for successor

Cencora has announced that Chief Financial Officer James F. Cleary will retire effective 30 June 2026. The pharmaceutical solutions company has engaged an executive search firm to identify potential successors from internal and external candidates. Cleary, 62, has served as CFO since November 2018 and joined Cencora in February 2015 following its acquisition of MWI Veterinary Supply, where he had been chief executive officer for over a decade. He will serve in an advisory capacity through the end of 2026 to ensure a smooth transition. Cencora reaffirmed its previously issued adjusted diluted earnings per share guidance range of $17.45 to $17.75 for fiscal year 2026. The company, ranked number 10 on the Fortune 500, generates more than $300 billion in annual revenue.

TradingView
Feb 11th, 2026
Cencora prices $3B senior notes offering across multiple maturities

Cencora has priced a $3 billion senior notes offering across various maturities, the company announced on 10 February 2026. No further details about the specific maturities, interest rates or intended use of proceeds were disclosed in the announcement.

Yahoo Finance
Feb 4th, 2026
Cencora raises fiscal 2026 guidance after completing OneOncology acquisition

Cencora reported 12% adjusted operating income growth and 9% adjusted diluted EPS growth in its fiscal 2026 first quarter, driven by its US healthcare solutions business. The company raised its full-year guidance to reflect year-over-year adjusted operating income growth of 11.5% to 13.5%. CEO Robert Mauch announced the completion of Cencora's acquisition of the majority remaining equity interest in OneOncology. The deal strengthens Cencora's specialty pharmaceutical leadership and MSO (management services organisation) platform. Cencora's strategy focuses on three priorities: strengthening leadership in specialty pharmaceuticals, partnering with market leaders, and enhancing patient access to pharmaceuticals. The company is leveraging technology and advanced analytics to improve customer experience and operational excellence whilst expanding its pharmaceutical-centric MSO footprint.

Yahoo Finance
Feb 4th, 2026
Cencora beats profit estimates on specialty drug demand, completes $5B OneOncology acquisition

Cencora beat Wall Street's first-quarter profit estimates on Wednesday, driven by sustained demand for specialty medicines and GLP-1 therapies. The drug distributor reported adjusted earnings of $4.08 per share, exceeding analysts' expectations of $4.04. The company completed its $5 billion acquisition of OneOncology from TPG in December, strengthening its presence in cancer care. It raised its fiscal 2026 adjusted operating income growth forecast to 11.5% to 13.5%, up from 8% to 10% previously. However, quarterly revenue of $85.93 billion fell short of expectations of $86.03 billion, sending shares down 5% in pre-market trading. Sales at its largest unit, US healthcare solutions, rose 5% year-over-year to $76.2 billion, boosted by prescription volumes of weight-loss drugs and specialty medicines.